About NEUROPATHIX, INC
Neuropathix, Inc. is a biopharmaceutical company focused on the research and development of breakthrough therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic pain. The company has a subsidiary, Kannalife Sciences, Inc., which has received significant grants from organizations such as the Michael J. Fox Foundation and the National Institute of Neurological Disorders and Stroke.
Research and development of novel therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic painDevelopment of patented cannabinoid-inspired molecules for therapeutic usePre-clinical drug discovery and development processesCommercialization of over-the-counter cosmeceutical assets through subsidiary Dermique Incorporated
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NEUROPATHIX, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.